Q J Med 2001; 94: 527-531
© 2001 Association of Physicians
Prevalence and significance of the familial Mediterranean fever gene mutation encoding pyrin Q148
From the Centre for Amyloidosis and Acute Phase Proteins, Department of Medicine, Royal Free and University College Medical School, Royal Free Campus, London, UK
Received 2 May 2001 and in revised form 8 August 2001
Familial Mediterranean fever (FMF) is caused by more than 25 mutations in the gene MEFV, which encodes pyrin (marenostrin), a protein implicated in the regulation of neutrophil activity. Pyrin Q148, is one of the five most common variants in populations in which FMF typically occurs. Our identification of the pyrin Q148 allele in several patients from ethnic groups in which FMF is not classically recognized who had longstanding fevers or AA amyloidosis prompted us to study the prevalence of pyrin Q148 in healthy British, Indian and Chinese subjects. The gene frequency was also sought in 50 British Caucasian patients with inflammatory arthritis, 25 of whom had AA amyloidosis, five Punjabi Indians with AA amyloidosis complicating inflammatory arthritis, and seven British Caucasian patients with uncharacterized longstanding fever syndromes. The allele frequency for pyrin Q148 was 21%, 15% and 0%, respectively, among Punjabi Indian, Chinese and Caucasian British controls, and was significantly increased among the patients with AA amyloidosis and the patients with obscure fever syndromes (p<0.01). Pyrin Q148 is a polymorphism and occurs widely in global terms, and, although it may cause FMF when associated with certain other MEFV mutations, homozygosity for Q148 alone must usually be insufficient to produce FMF in the populations studied. The association of pyrin Q148 with AA amyloidosis and with obscure chronic inflammatory diseases suggests the variant may augment inflammation non-specifically, which might have been beneficial during evolution, but could potentially exacerbate many chronic inflammatory disorders.
Address correspondence to Professor P.N. Hawkins, Centre for Amyloidosis and Acute Phase Proteins, Department of Medicine, Royal Free and University College Medical School, Royal Free Campus, Rowland Hill Street, London NW3 2PF. e-mail:p.n.hawkins{at}rfc.ucl.ac.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. TSUCHIYA-SUZUKI, M. YAZAKI, A. NAKAMURA, K. YAMAZAKI, K. AGEMATSU, M. MATSUDA, and S.-I. IKEDA Clinical and Genetic Features of Familial Mediterranean Fever in Japan J Rheumatol, August 1, 2009; 36(8): 1671 - 1676. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Schreiber, H. Lachmann, and C. Mackworth-Young Possible familial Mediterranean fever in a Caucasian patient with systemic lupus erythematosus Lupus, August 1, 2008; 17(8): 752 - 753. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Farasat, I. Aksentijevich, and J. R. Toro Autoinflammatory Diseases: Clinical and Genetic Advances Arch Dermatol, March 1, 2008; 144(3): 392 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Rabinovich, A Livneh, P Langevitz, N Brezniak, E Shinar, M Pras, and Y Shinar Severe disease in patients with rheumatoid arthritis carrying a mutation in the Mediterranean fever gene Ann Rheum Dis, July 1, 2005; 64(7): 1009 - 1014. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Topaloglu, F Ozaltin, E Yilmaz, S Ozen, B Balci, N Besbas, and A Bakkaloglu E148Q is a disease-causing MEFV mutation: a phenotypic evaluation in patients with familial Mediterranean fever Ann Rheum Dis, May 1, 2005; 64(5): 750 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ozen, N. Besbas, A. Bakkaloglu, and E. Yilmaz Pyrin Q148 mutation and familial Mediterranean fever QJM, May 1, 2002; 95(5): 332 - 333. [Full Text] [PDF]
|
|